Profile
Manisha Pai is currently Executive Director-Investor Relations at Vertex Pharmaceuticals, Inc. since 2020.
Former roles include Head-Public Relations at Millennium Pharmaceuticals, Inc. from 2008 to 2013, Head-Public Relations at Pharmacyclics LLC from 2013 to 2014, Head-IR & Corporate Communications at Epizyme, Inc. from 2014 to 2015, Head-IR & Corporate Communications at Genetix Biotherapeutics, Inc. from 2015 to 2017, and Vice President-Investor Relations & Communications at Magenta Therapeutics, Inc. Education includes undergraduate studies at Amherst College.
Manisha Pai active positions
| Companies | Position | Start |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01/09/2020 |
Former positions of Manisha Pai
| Companies | Position | End |
|---|---|---|
| GENETIX BIOTHERAPEUTICS, INC. | Investor Relations Contact | 01/10/2017 |
| EPIZYME, INC. | Investor Relations Contact | 01/04/2015 |
| PHARMACYCLICS, INC. | Corporate Officer/Principal | 01/01/2014 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01/07/2013 |
| MAGENTA THERAPEUTICS | Investor Relations Contact | - |
Training of Manisha Pai
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Pharmacyclics LLC
Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
bluebird bio, Inc.
bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Amherst College
Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epizyme, Inc.
Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Magenta Therapeutics, Inc.
Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
- Stock Market
- Insiders
- Manisha Pai
















